Skip to main content
Premium Trial:

Request an Annual Quote

EMD to Use Starpharma's Dendrimers for DNA and siRNA Transfection Research

NEW YORK (GenomeWeb News) — EMD Biosciences will use Starpharma’s dendrimers for DNA and siRNA transfection research, EMD said today.
Under the terms of the license and supply agreement, Starpharma’s US subsidiary Dendritic Nanotechnologies will supply EMD with the Priostar technology in exchange for royalties and milestones.
DNT will retain the full rights to use Priostarall for in vivo transfection research.
Lisa Johnson, EMD’s vice president of corporate development, said the company plans to develop new transfect ion reagents, which EMD will market under the Novagen brand. 
Johnson said the company sees the transfection reagent market as “rapidly growing,” and said EMD plans to make this technology “a foundation for future product platforms."
Financial terms of the agreement were not released.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.